Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Chemical Allergen [EPC]
Sus Scrofa Ear is a standardized allergenic extract derived from porcine tissue, primarily used in the diagnosis and treatment of hypersensitivity reactions. It belongs to the class of Standardized Chemical and Food Allergenic Extracts.
Name
Sus Scrofa Ear
Raw Name
SUS SCROFA EAR
Category
Standardized Chemical Allergen [EPC]
Drug Count
9
Variant Count
10
Last Verified
February 17, 2026
About Sus Scrofa Ear
Sus Scrofa Ear is a standardized allergenic extract derived from porcine tissue, primarily used in the diagnosis and treatment of hypersensitivity reactions. It belongs to the class of Standardized Chemical and Food Allergenic Extracts.
Detailed information about Sus Scrofa Ear
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Ear.
Sus Scrofa Ear refers to a specialized biological allergenic extract derived from the ear tissue of the domestic pig (Sus scrofa). In a clinical and pharmacological context, this substance is categorized by the FDA as a Standardized Chemical Allergen [EPC], as well as a Non-Standardized Plant and Food Allergenic Extract [EPC]. While the nomenclature may seem unusual to the layperson, it represents a critical tool in the field of clinical immunology and allergy medicine. Specifically, these extracts are utilized to diagnose Type I hypersensitivity (immediate-type allergy) to porcine-derived proteins and, in some cases, to facilitate allergen immunotherapy (desensitization).
Sus Scrofa Ear belongs to a broader class of drugs known as allergenic extracts. These are complex mixtures of proteins, glycoproteins, and polysaccharides. When a patient is exposed to these extracts via skin testing, the presence of specific Immunoglobulin E (IgE) antibodies on the surface of mast cells triggers a localized inflammatory response. This response, often referred to as a 'wheal and flare' reaction, allows clinicians to confirm whether a patient is sensitized to porcine antigens. The FDA has a long history of regulating these biologics through the Center for Biologics Evaluation and Research (CBER), ensuring that the potency and purity of the extracts are maintained across different manufacturing lots.
The mechanism of action for Sus Scrofa Ear is rooted in the fundamental principles of immunology. It does not act on a traditional receptor-ligand system like a beta-blocker or an antidepressant. Instead, it acts as an antigen that bridges pre-existing IgE antibodies. In a sensitized individual, the immune system has previously identified porcine proteins as 'foreign' and produced IgE antibodies specific to those proteins. These IgE antibodies are 'fixed' to high-affinity receptors (FcεRI) on the surface of mast cells in the skin and basophils in the blood.
When Sus Scrofa Ear extract is introduced into the skin (via prick or intradermal injection), the allergenic proteins bind to the IgE antibodies. This binding causes the IgE receptors to cross-link, which signals the mast cell to undergo degranulation. During degranulation, the cell releases pre-formed mediators such as histamine, proteases, and heparin, and begins synthesizing new mediators like leukotrienes and prostaglandins. These chemicals cause local vasodilation (redness or 'flare') and increased capillary permeability (swelling or 'wheal'). This physiological cascade is what healthcare providers measure to determine an allergic profile.
Unlike traditional systemic medications, the pharmacokinetics of allergenic extracts like Sus Scrofa Ear are not typically measured in terms of plasma concentration or half-life, as the intended effect is localized and the systemic absorption is a secondary (and often avoided) event.
Sus Scrofa Ear is indicated for several specific clinical scenarios, primarily within the realm of allergy and immunology:
Sus Scrofa Ear is typically available in the following formats for clinical use:
> Important: Only your healthcare provider can determine if Sus Scrofa Ear is right for your specific condition. The administration of allergenic extracts must be performed in a clinical setting equipped to treat anaphylaxis.
Dosage for Sus Scrofa Ear is highly individualized and is not measured in milligrams like standard pharmaceuticals. Instead, it is measured in Protein Nitrogen Units (PNU) or Weight/Volume (W/V) ratios.
For the initial assessment, a single drop of the extract (typically at a concentration of 1:10 or 1:20 w/v) is applied to the skin, usually on the forearm or back. A sterile lancet is then used to prick the skin through the drop. A positive reaction is generally defined as a wheal (a raised, pale bump) that is 3mm larger in diameter than the negative control (saline).
If the prick test is negative but the clinical history strongly suggests an allergy, a healthcare provider may perform an intradermal test. This involves injecting 0.02 to 0.05 mL of a much more dilute extract (e.g., 1:1000 or 1:500 w/v) into the skin to create a small bleb. This is a more sensitive test but carries a higher risk of systemic reactions.
Sus Scrofa Ear is generally considered safe for use in children, provided the testing is performed by a pediatric allergist. The procedure is identical to adult testing, though the number of tests performed in a single session may be limited to minimize discomfort and the risk of a systemic reaction. There is no specific age-based dosage adjustment, as the test relies on the skin's local immunological reactivity rather than systemic metabolism.
No dosage adjustments are required for patients with renal impairment, as the extract is not cleared through the kidneys in a manner that would affect the local skin response.
No dosage adjustments are required for patients with hepatic impairment.
Elderly patients may have 'thinner' skin (atrophy) or reduced skin reactivity. Healthcare providers may need to interpret results more cautiously, as the wheal and flare response may be diminished compared to younger adults. However, the concentration used remains the same.
Sus Scrofa Ear is never self-administered by the patient. It must be administered by a trained healthcare professional (usually an allergist or immunologist).
As this is a diagnostic tool or a strictly scheduled immunotherapy, 'missing a dose' usually refers to a missed immunotherapy appointment. If a dose in an immunotherapy schedule is missed, the next dose may need to be reduced to avoid an adverse reaction, depending on how much time has elapsed. Consult your allergist immediately if you miss a scheduled injection.
An 'overdose' in the context of Sus Scrofa Ear usually means the administration of too much allergen or an injection that accidentally enters a blood vessel.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to perform skin testing at home without medical guidance.
The most frequent side effects associated with Sus Scrofa Ear are localized to the site of administration. These are often expected outcomes of the diagnostic process rather than 'adverse' events in the traditional sense.
> Warning: Stop the procedure and call for emergency help immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term side effects associated with the one-time diagnostic use of Sus Scrofa Ear. In the context of long-term immunotherapy, the primary risk is the cumulative risk of systemic reactions. There is no evidence that these extracts cause cancer, organ damage, or permanent changes to the immune system other than the intended desensitization.
Allergenic extracts, including Sus Scrofa Ear, can cause severe, life-threatening systemic allergic reactions, including anaphylaxis.
Report any unusual symptoms to your healthcare provider. Even a minor 'itchy throat' or 'feeling of doom' should be reported immediately during the observation period.
Sus Scrofa Ear is a potent biological substance. Its use is restricted to diagnostic and therapeutic purposes under strict medical supervision. It is not a medication for the treatment of symptoms but a tool to identify the cause of symptoms. Patients must provide a full medical history, including all current medications, as many drugs can interfere with the safety and accuracy of the test.
No FDA black box warnings for Sus Scrofa Ear. (Note: While many allergenic extracts carry a general class warning for anaphylaxis as detailed in the side effects section, specific individual 'Black Box' labels vary by manufacturer. Always check the specific package insert for the brand being used.)
No routine lab tests (like blood counts or liver enzymes) are needed for Sus Scrofa Ear. However, the following monitoring is mandatory during the procedure:
Sus Scrofa Ear does not cause sedation or cognitive impairment. Most patients can drive themselves home after the 30-minute observation period, provided they have not experienced a systemic reaction or received emergency medications like antihistamines that cause drowsiness.
Alcohol should be avoided for 24 hours before and after testing. Alcohol can increase peripheral blood flow (vasodilation), which may exacerbate a local or systemic allergic reaction and potentially lead to a more severe response.
If a patient experiences a systemic reaction during testing or immunotherapy, the healthcare provider will determine if the procedure should be discontinued permanently or if the concentration should be significantly reduced in future sessions.
> Important: Discuss all your medical conditions with your healthcare provider before starting Sus Scrofa Ear.
While there are no drugs that are strictly 'contraindicated' in the sense of a chemical cross-reaction, certain drugs make the use of Sus Scrofa Ear dangerously unsafe:
These medications do not necessarily make the test 'unsafe,' but they can cause False Negative results by suppressing the skin's reaction:
Sus Scrofa Ear does not interfere with standard blood work (CBC, CMP). However, it will obviously interfere with other allergy tests (like a RAST or ImmunoCAP blood test) if they are performed immediately after a large skin reaction, as the skin testing itself can briefly consume or alter circulating IgE levels.
For each major interaction, the management strategy is usually to discontinue the interfering medication for a specific period (washout period) before the test is performed. If the medication (like a beta-blocker) cannot be safely stopped, the allergist may opt for a blood-based allergy test (IgE serum test) instead of skin testing.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Conditions where Sus Scrofa Ear must NEVER be used include:
Patients who are allergic to Sus Scrofa Ear may also show cross-reactivity with:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Sus Scrofa Ear.
Sus Scrofa Ear is categorized as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known if the extract can cause fetal harm. The primary concern during pregnancy is not the extract itself, but the potential for a systemic reaction (anaphylaxis) in the mother. Anaphylaxis can lead to a sudden drop in blood pressure and uterine contraction, which can cause fetal distress, miscarriage, or preterm labor. Consequently, diagnostic skin testing is usually deferred until after delivery unless the information is critical for managing a life-threatening condition.
It is not known whether the allergenic proteins in Sus Scrofa Ear pass into breast milk. However, because these are large proteins that are typically broken down in the mother's digestive system or local tissue, the risk to a nursing infant is considered extremely low. Breastfeeding is generally not a contraindication for diagnostic skin testing.
Sus Scrofa Ear is used in the pediatric population to diagnose allergies to pigs or porcine-derived medical products. While safe, the emotional stress of needle pricks should be managed. In very young infants (under 6 months), the skin's mast cell density and reactivity may be lower, leading to smaller wheal sizes. Pediatricians often use a 'multi-test' device to apply several allergens at once to minimize the time and discomfort involved. Testing is NOT approved for use in home settings; it must be done in a clinical environment.
In patients over age 65, the skin undergoes physiological changes, including loss of elasticity and decreased vascularity. This can result in smaller wheal and flare responses. Additionally, elderly patients are more likely to be taking medications like beta-blockers or ACE inhibitors for cardiovascular health, which increases the risk profile of the test. Healthcare providers should prioritize serum (blood) IgE testing for elderly patients with significant cardiac history.
There is no evidence that renal impairment affects the localized skin response to Sus Scrofa Ear. No dose adjustments are necessary for patients with chronic kidney disease or those on dialysis. The proteins are not cleared by the kidneys in their active form.
Liver disease does not affect the immunological mechanism of a skin prick test. No dosage adjustments are required for patients with cirrhosis or other hepatic conditions. However, if the patient has severe liver failure with associated coagulopathy (bleeding risk), the intradermal injection should be performed with caution to avoid hematoma.
> Important: Special populations require individualized medical assessment. Always inform your allergist of your pregnancy status or any underlying organ dysfunction.
Sus Scrofa Ear functions as an exogenous antigen. The specific proteins within the extract (such as porcine serum albumin, immunoglobulins, and epithelial keratins) act as epitopes. In a sensitized individual, these epitopes are recognized by the Fab (antigen-binding) portion of specific IgE antibodies. These IgE antibodies are already bound to the FcεRI receptors on mast cells via their Fc portion.
The binding of the Sus Scrofa Ear allergen causes 'cross-linking' of two or more IgE receptors. This physical change in the receptor structure activates an intracellular signaling cascade involving tyrosine kinases (like Syk). This leads to an influx of calcium ions and the subsequent fusion of storage granules with the cell membrane, releasing histamine and other inflammatory mediators into the local tissue. This is the classic Type I Hypersensitivity reaction.
| Parameter | Value |
|---|---|
| Bioavailability | Localized (Minimal systemic) |
| Protein Binding | N/A (Acts as antigen) |
| Half-life | Minutes (Local) |
| Tmax | 15-20 Minutes (for wheal) |
| Metabolism | Local Proteolysis |
| Excretion | Cellular degradation |
Sus Scrofa Ear is classified as an Allergenic Extract. It is grouped with other animal-derived allergens (like cat dander or bovine epithelium) and is regulated as a biological product. It is distinct from synthetic chemicals because its potency is determined by its biological activity in a living system or a bioassay.
Medications containing this ingredient
Common questions about Sus Scrofa Ear
Sus Scrofa Ear is primarily used as a diagnostic tool by allergists to determine if a patient has a Type I hypersensitivity (allergy) to pig-derived proteins. This is important for people who have reactions after eating pork or after being exposed to pigs in occupational settings like farming. It is also used to screen patients who may need porcine-derived medical products, such as certain heart valves or medications like heparin. The extract is applied to the skin to see if it triggers a localized allergic response. In rare cases, it may be used in immunotherapy to help desensitize a patient to these allergens.
The most common side effects are localized to the area where the test was performed. Most patients experience a 'wheal and flare' reaction, which looks like a raised, itchy bump similar to a mosquito bite. This is actually the desired result for a positive test and indicates an allergy. Other common effects include redness, itching, and minor swelling at the site. These symptoms usually appear within 20 minutes and fade away within a few hours. Some people may experience a 'late-phase' reaction where the swelling returns several hours later, but this is generally not serious.
It is strongly recommended that you avoid alcohol for at least 24 hours before and after being tested with Sus Scrofa Ear. Alcohol acts as a vasodilator, meaning it widens your blood vessels and increases blood flow to the skin. This can make a local allergic reaction more severe or, more importantly, increase the risk of a systemic reaction (anaphylaxis) by helping the allergen spread more quickly through your body. Alcohol can also interfere with your body's ability to respond to emergency medications if a reaction occurs. Always follow your doctor's specific pre-test instructions regarding diet and alcohol.
Sus Scrofa Ear is generally avoided during pregnancy unless the diagnostic information is absolutely essential. While the extract itself is not known to be toxic to the fetus, the risk of a systemic allergic reaction (anaphylaxis) in the mother poses a significant danger. Anaphylaxis can cause a sharp drop in blood pressure and reduced oxygen flow to the placenta, which can harm the developing baby. Most allergists prefer to wait until after the baby is born to conduct allergy testing. If you are pregnant or planning to become pregnant, be sure to inform your healthcare provider before any testing is scheduled.
When used for diagnostic skin testing, Sus Scrofa Ear works very quickly. The 'immediate-phase' reaction typically begins within 5 to 10 minutes of the extract being applied to the skin. The reaction usually reaches its peak size (the maximum wheal and flare) between 15 and 20 minutes. This is why you are required to stay in the doctor's office for a period of time after the test—so the results can be accurately measured at their peak and so you can be monitored for safety. If used in immunotherapy, the effects take much longer, often requiring months of regular injections to see a reduction in allergy symptoms.
Since Sus Scrofa Ear is typically used as a one-time diagnostic test, 'stopping' it is not usually an issue. However, if you are receiving Sus Scrofa Ear as part of an immunotherapy (allergy shot) program, you should not stop the injections without consulting your allergist. Stopping suddenly will halt the desensitization process, and your allergy symptoms will likely return to their original severity. If you miss an injection, your doctor may need to adjust your next dose to ensure it is safe. Always communicate with your clinical team before making changes to a scheduled treatment plan.
If you miss an appointment for a diagnostic test, simply reschedule with your doctor as soon as possible. If you are on an immunotherapy schedule and miss a dose, contact your allergist's office immediately. Do not try to 'double up' on your next dose. Depending on how long it has been since your last injection, your doctor may need to repeat your previous dose or even reduce the concentration to prevent a reaction. Consistency is key in immunotherapy, so try to stay on the schedule provided by your healthcare team.
There is no evidence that Sus Scrofa Ear causes weight gain. It is a biological extract used in very small amounts for diagnostic testing or immunotherapy. Unlike some medications like oral steroids (e.g., prednisone) or certain antidepressants, allergenic extracts do not affect your metabolism, appetite, or fat storage. Any localized swelling at the test site is temporary and due to inflammation, not an increase in body fat. If you experience unexpected weight gain, you should discuss it with your primary care physician to find the underlying cause.
Sus Scrofa Ear can be used while you are taking many other medications, but there are important exceptions. Antihistamines, many antidepressants, and some sleep aids must be stopped several days before testing because they can block the skin's reaction and lead to a false negative result. More importantly, beta-blockers used for heart conditions can make the test dangerous because they interfere with the treatment of a severe allergic reaction. You must provide your doctor with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking before the test.
The concept of 'generic' vs. 'brand name' is slightly different for biological products like allergenic extracts. Sus Scrofa Ear is produced by several different specialized laboratories (such as Greer Laboratories or HollisterStier). While they all contain extracts from the same animal, they are not considered identical generics in the way a chemical pill like ibuprofen is. Each manufacturer has its own proprietary method for creating and standardizing the extract. Your allergist will typically use a consistent brand to ensure that your test results and treatments are comparable over time.